Finance Ministry says SEBI nod not needed for ULIP sales
NEW DELHI (Reuters) - The finance ministry said on Saturday life insurers could sell unit-linked insurance plans (ULIPs) without seeking a nod from the capital markets regulator, ending a spat between regulators over the hybrid products.
The presidential decree permitting such sales went into force late on Friday, the finance ministry said in statement. Under the law, such orders issued when parliament is not in session must be confirmed by lawmakers in their next sitting.
The capital markets regulator and the insurance regulator had locked horns on who should regulate ULIPs, mutual fund instruments with an added life cover, given the products combined insurance and investments.
The Securities and Exchange Board of India (SEBI) had in April barred 14 life insurance companies from selling ULIPs without its approval. The Insurance Regulatory Development Authority (IRDA) argued SEBI had no authority to do so.
After the finance ministry intervened, the two decided to maintain the status quo.
"Life insurance business shall include any Unit Linked Insurance Policy or scripts or any such instruments. This would set at rest all the issues regarding ULIPs between two financial regulators," the finance ministry said in the statement.
Parliament will next meet for the monsoon session, which generally starts in July.
(Reporting by C.J. Kuncheria; editing by Patrick Graham)
(For more news on Reuters India, click in.reuters.com)
- Tweet this
- Share this
- Digg this
- Boxer Sarita Devi faces action after refusing medal at Asian Games
- Hong Kong's embattled leader believes protests could last weeks-source
- Ebola outbreaks in Nigeria, Senegal, appear contained: CDC reports
- UPDATE 2-EU-Russia gas duel deepens with Slovakia supply cut
- Obama, Modi work to deepen improving U.S.-India ties
India could run out of a critical medicine in its free HIV/AIDS drugs programme in three weeks due to bureaucratic bungling, a senior government official said, leaving more than 150,000 sufferers without life-saving drugs for about a month. Full Article